According to ICH E6(R3), a service provider is a person or organization that provides trial-related services for the sponsor or investigator. This umbrella term includes commercial, academic, and other providers, such as Contract Research Organizations, central laboratories, IRT providers, courier services, or electronic data capture providers.
Role in the Study System
The term is deliberately broad. A service can originate with the sponsor or the investigator and still be part of the clinical trial. The crucial factor is whether it is used to fulfill a trial-related activity. This can include laboratory analyses, data management, monitoring, drug logistics, randomization systems, statistical services, or technical platforms. An academic partner can also be a service provider if they offer such a service.
ICH E6(R3) thus moves away from the narrow usage that primarily associated outsourced services with CROs. A Contract Research Organization is now a possible sub-category of a service provider, not its synonym. This hierarchy makes it easier to uniformly consider all externally provided or subcontracted services in risk analysis, agreements, and oversight. For quality, it is not the name of a company that matters, but the significance of its activity for participant protection and data reliability.
Agreement, Selection, and Quality Requirements
If a service provider assumes sponsor tasks, the delegated and assumed activities must be documented in an agreement. Sponsor tasks not explicitly delegated remain with the sponsor. The service provider should apply an appropriate quality management system and report incidents that could affect participant safety or results. Significant changes to delegated activities require an update to the agreement.
The sponsor assesses the suitability and selects service providers in a way that ensures they can adequately perform the activity. For this, the sponsor needs access to relevant information, such as standard operating procedures and performance indicators. The sponsor’s oversight also extends to activities that a service provider subcontracts. For services under the investigator’s responsibility, the sponsor must inform the investigator of the intended service provider; however, the investigator’s responsibility for these activities remains with the investigator.
Distinction from CRO, Sponsor, and Study Site
A CRO is a specialized service provider that often undertakes multiple sponsor tasks. The related entry ‘contract-research-organization’ therefore remains relevant, but it does not describe central laboratories, technology providers, or couriers. A Site Management Organization can also provide services for study sites or study processes; it is also not to be equated with the general umbrella term. The new conceptual hierarchy is therefore: CRO and, if applicable, Site Management Organization as specific forms, with service provider as the overarching category.
A service provider does not become a sponsor merely by outsourcing. According to ICH E6(R3), the sponsor bears ultimate responsibility for delegated sponsor tasks, including participant protection and data reliability. The study site is also different: it is the location or facility where the trial is conducted under the investigator’s responsibility. A service provider can operate there but does not replace either the institution or the investigator’s role.
The service provider’s role can change within a study. A provider might initially only supply a system and later take on additional trial-related activities. In such cases, the task description, qualification, and oversight must be re-evaluated. Similarly, a distinction must be made between access to study-related information and access to personal data. Agreements and technical authorizations must ensure the confidentiality, data integrity, and required availability of documents. A well-maintained list of all involved service providers facilitates the updating of risk analysis, communication plans, and archiving overviews.
For critical services, requirements should be reviewed not only before the activity begins but also in the event of significant changes, safety incidents, and contract termination. This maintains transparency regarding which external contributions genuinely support the study.
Relevance for clinical trials
The multitude of specialized services creates interface risks. An unclear task description can lead to gaps in safety reporting, data access, reconstructability, or escalation. In practice, selection, qualification, written task allocation, communication channels, key performance indicators, and the handling of subcontractors must be aligned. Inspections and audits consider not only the contract but also whether the sponsor effectively oversees the service and critical incidents.
Full-service CROs like Mediconomics assist with service provider selection, vendor qualification, contract and responsibility matrices, establishing oversight metrics, and coordinating data management, central laboratories, IRT, and study sites. They can also align documentation requirements in the Trial Master File, set up escalation pathways, and organize the tracking of quality-relevant deviations.
Frequently Asked Questions (FAQ)
Is every CRO a service provider?
Yes. A CRO is a typical service provider, but the term includes numerous other individuals and organizations providing trial-related services.
Can a service provider delegate sponsor duties?
Subcontractors may be used. However, the sponsor must ensure adequate oversight of important delegated activities, including subcontracted services.
Does the service provider assume the sponsor’s overall legal responsibility?
No. Delegated activities may lie with the service provider, but the sponsor’s ultimate responsibility for its trial-related tasks remains unaffected.
Regulatory References
- ICH E6(R3), Glossary – Definition of a service provider as a person or organization providing trial-related services.
- ICH E6(R3), Sections 3.6.4 to 3.6.10 – Agreements, selection, quality, and oversight for delegated activities.
- Regulation (EU) No 536/2014, Article 71 – Written delegation of sponsor tasks without relinquishing sponsor responsibility.
- EudraLex Volume 10, Chapter V, Section 3.1.6 – Documented agreements between parties, including CROs.
